SVRA
NASDAQ · Biotechnology
Savara Inc
$5.37
-0.05 (-0.92%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,072.1% upside
Low Target
$52.50
Average Target
$62.94
High Target
$80.97
Current Price
$5.37
Current
$5.37
$5.37
Target
$62.94
$62.94
$52.50
$62.94 avg
$80.97
Scenario Analysis
Bear Case
$52.50
877.7%
Low target
Base Case
$62.94
+1,072.1%
Avg target
Bull Case
$80.97
+1,407.8%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$7.01
-23.3% from high
52-Week Low
$3.34
+60.8% from low
Target vs 52W High
$62.94
+798.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |